“A more reliable way of assembling candidate vaccines could make them much cheaper and improve the chances of vaccines against these illnesses. A faster way of assembling vaccines may also help with the rapid development of new vaccines against unforeseen disease outbreaks,” Darren Leneghan, PhD, a researcher involved with the project, said in a statement.
The team successfully encoded the sticky proteins on virus-like particles — commonly used as a basis for vaccines — from a range of antigens related to malaria and cancer, suggesting that quick linking could be performed to produce stable vaccines.
“This simple, efficient and modular decoration of nanoparticles should accelerate vaccine development, as well as other applications of nanoparticle devices,” the authors concluded.
More articles on infection control:
How clean is clean-shaven? Study finds beardless healthcare workers carry more bacteria on their faces
CDC, American College of Physicians issue new guidelines on antibiotic prescription
Imaging innovation enables easier diagnosis of fungal lung infections
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.